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ABSTRACT
Epstein–Barr virus (EBV) infects and transforms
human primary B cells inducing indefinite prolifer-
ation. To investigate the potential participation of
chromatin mechanisms during the EBV-mediated
transformation of resting B cells we performed an
analysis of global changes in histone modifications.
We observed a remarkable decrease and redistribu-
tion of heterochromatin marks including H4K20me3,
H3K27me3 and H3K9me3. Loss of H4K20me3 and
H3K9me3 occurred at constitutive heterochromatin
repeats. For H3K27me3 and H3K9me3, comparison
of ChIP-seq data revealed a decrease in these
marks in thousands of genes, including clusters of
HOX and ZNF genes, respectively. Moreover,
DNase-seq data comparison between resting and
EBV-transformed B cells revealed increased endo-
nuclease accessibility in thousands of genomic
sites. We observed that both loss of H3K27me3
and increased accessibility are associated with
transcriptional activation. These changes only
occurred in B cells transformed with EBV and not
in those stimulated to proliferate with CD40L/IL-4,
despite their similarities in the cell pathways
involved and proliferation rates. In fact, B cells
infected with EBNA-2 deficient EBV, which have
much lower proliferation rates, displayed similar
decreases for heterochromatic histone marks. Our
study describes a novel phenomenon related to
transformation of B cells, and highlights its inde-
pendence of the pure acquisition of proliferation.
INTRODUCTION
Quiescent differentiated B lymphocytes, like many other
types of differentiated cells, have a relatively restricted
transcriptome generated through the differentiation
process. This restriction of the transcription program in
differentiated resting cells is associated with the epigenetic
silencing of the genome, which forms blocks of faculta-
tive heterochromatin (1). Histone modifications
associated with facultative heterochromatin include H3
trimethylation at Lys 27 (H3K27me3), H3 di- and
trimethylation at Lys 9 (H3K9me2/H3K9me3) and H3
and H4 hypoacetylation (2). This type of heterochromatin
coexists with constitutive heterochromatin, another class
of silent chromatin quite different from facultative hetero-
chromatin. Constitutive heterochromatin comprises gene-
poor DNA containing highly repetitive sequences, is
characterized by H4K20me3 as well as H3 and H4
hypoacetylation (2), and is independent of cell differenti-
ation and proliferation status, as well as the level of tran-
scriptional activity. Both types of heterochromatin are
highly condensed and are less accessible to endonucleases
than euchromatin, characteristic of transcriptionally
active regions. In fact, there is a general notion that
certain histone modifications are associated with a par-
ticular chromatin structure. One of such examples is
H3K27me3 that is generally associated with condensed
facultative heterochromatin, less accessible to nucleases,
and both associated with low levels of expression.
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The B cell compartment in peripheral blood consists of
quiescent naı̈ve and memory cells that can be activated
and driven into proliferation in response to encountering
an antigen. This phenomenon can be replicated in vitro
through co-stimulation with IL-4 and CD40L that leads
to a finite proliferative lifespan. In contrast, experimental
infection of resting B cells (RBLs) with Epstein–Barr virus
(EBV) results in the establishment of lymphoblastoid cell
lines (LCLs) with indefinite proliferation (3). Transition
from quiescence to proliferation involves major changes
in gene expression, nuclear reorganization, and requires
the participation of various pathways, including cell sig-
naling and cell cycle factors and elements of the epigen-
etics and chromatin machinery. Infection of B cells with
EBV, which is highly prevalent in humans, is an excellent
model not only for investigating the molecular mechan-
isms associated with the transition from quiescence to pro-
liferation but also for understanding those related with
growth transformation. In fact, EBV-associated changes
in B cells are relevant to the development and progression
of lymphomas (4–6), lymphoproliferative disorders in
immune-suppressed individuals, and autoimmune dis-
orders like rheumatoid arthritis, systemic lupus erythema-
tosus and multiple sclerosis (7). In vitro, EBV efficiently
immortalizes primary RBLs, converting them into per-
manently growing LCLs. In vitro infection results in the
activation of a specific viral gene expression program that
involves expression of six nuclear antigens (EBNA-1, -2,
3A, -3B, -3C and -LP) and three membrane proteins
(LMP-1, -2A and -2B). Five of these proteins are essential
for transformation. For instance, LMP-1 is required for
the establishment of cell transformation in vitro (8) and is
required for continuous proliferation (9). Infection of B
cells with EBV is similar to the physiological stimulation
with CD40L plus IL-4 (3), T cell-derived mitogens, and in
both cases involves the activation of the NF-kB pathway.
EBV-mediated transformation of RBLs to proliferating
lymphoblasts involves changes to the expression profile
and is likely to result in reorganization of the histone
modification profiles. In this process, some of the
changes in the histone profiles occur through the direct
recruitment of histone modification enzymes by viral tran-
scription factors like EBNA-2 (10,11) and are specific to
the activity of EBV proteins. Others perhaps occur
through indirect mechanisms or even as a result of the
acquisition of the proliferation. In this process it is essen-
tial to identify which of these effects are EBV-specific and
which could be classified as general changes associated
with the transformation from quiescent to proliferative
B cells, also as initial steps in lymphomagenesis.
In this study, we have investigated global changes in
histone modifications as well as accessibility to endonucle-
ases during the EBV-mediated transformation of RBLs to
proliferative lymphoblasts. In this transition, we have
observed a significant reduction of heterochromatic
histone modifications like H3K27me3, H3K9me3 and
H4K20me3 over time, whereas no significant changes in
H3K4me3 and other euchromatin-specific marks were
observed. A decrease in heterochromatin histone marks
occurred at repetitive elements for H4K20me3 and at
unique genomic sites for H3K9me3 and H3K27me3,
particularly those genomic regions highly enriched in
these marks, including ZNF and HOX gene clusters, re-
spectively. We have also observed that infection with EBV
results in increased endonuclease accessibility at thou-
sands of genomic sites. Both decrease in heterochromatic
histone modifications and increased accessibility to endo-
nucleases in proliferating versus RBLs are associated with
increased transcriptional activity. Changes in heterochro-
matin histone modifications are specific to EBV-mediated
transformation, whereas cytokine stimulated activation
and proliferation of B cells do not result in significant
decrease of these marks. In addition, B cells infected
with EBV particles deficient for EBNA-2 that result in
much lower proliferation rates also undergo decrease in
these marks. Our study describes the existence of global
changes in histone heterochromatin marks and chromatin
compaction in EBV-mediated transformation of B cells.
The comparison with IL-4/CD40L-stimulated cells and B
cells infected with mutant EBV particles highlights the
independence of this process with the acquisition of pro-
liferative properties providing novel clues of the existence
of specific epigenetic alterations in the growth transform-
ation of B cells.
MATERIALS AND METHODS
Ethics statement
Human blood samples used in this study came from
anonymous blood donors and were obtained from the
Catalan blood donation center (Banc de Sang i Teixits).
The blood anonymous donors received both verbal and
written information about the possibility that their blood
was used for research purposes, their questions were then
answered and they signed a consent form at the Banc de
Teixits. The Banc de Teixits follows the principles set out
in the WMA Declaration of Helsinki. The protocol used
to transform B cells from these anonymous donors with
EBV was approved by the Committee of Biosecurity of
IDIBELL (CBS) on 5 May 2011 and the Ethics
Committee of the University Hospital of Bellvitge
(CEIC) on 28 May 2011.
B cell isolation and transformation with EBV
Viable peripheral blood mononuclear cells (PBMCs) were
isolated by LymphoprepTM density gradient centrifuga-
tion from buffy-coats from anonymous blood donors.
RBLs were isolated by positive selection using CD19
MicroBeads (Miltenyi Biotec), or by depletion using a B
Cell Isolation Kit (Miltenyi Biotec). Isolated B cells were
immortalized with the supernatant of the 2089 EBV
variant made from 293 cells carrying a recombinant
B95.8 EBV genome (12). Preparations of the 2089 recom-
binant wild type EBV with a GFP insert or viruses deleted
for LMP-1 and EBNA-2 (13) were made from 293 cells
carrying the recombinant B95.8 EBV genomes, and
transfected with 0.5 mg BZLF1 (p509)+0.5 mg gp110
(pRA). We purified the encapsidated and enveloped
virus particles from culture supernatants by centrifugation
on an Optiprep (Axis Shield) self-generated gradient and
then quantitated by a qPCR assay amplifying a single
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copy gene, BALF5, using Namalwa cell line (two
integrated copies of EBV) as the standard. The multipli-
city of infection (MOI) was defined as the number of EBV
genomes in the purified virus preparations divided by the
number of target cells in culture. We then incubated
freshly isolated primary B cells with purified virus super-
natants at a 100MOI for 3 h at 37C. The virus-loaded B
cells were then plated according with the experiment.
B cell activation
Isolated B cells were cultured 5 106/3ml per well of a 6-
well plate with 50 ng/ml CD40L (Enzo Life Sciences) and
50 ng/ml IL-4 (Gentaur) and the B cell blasts were split at
a 1:2 ratio once a week. The percentages of activated and
proliferating B cells were detected by CD86 expression
measured by flow cytometry and tritiated thymidine
incorporation, respectively.
LMP-1 lentiviral infection
B cells activated during 4 days were infected with the
GFP-lentiviral vector expressing LMP-1, then added
appropriate numbers of cells to each plate, i.e. 1 105 B
cells to 1 well of a 24-well plate. We then added 2ml of
lentivirus supernatant to these cells and incubated at 37C
for 30min. Then the cells were centrifuged at 30C for 2 h
at 2200 rpm. After 18 h of incubation the medium
was replaced with fresh medium. The efficiency of the
infection was measured by the GFP expression in the
infected cells using FACS.
Quantification of cell proliferation by tritiated thymidine
incorporation
The isolated CD19 positive cells EBV-infected or CD40L/
IL-4-stimulated were plated in 24-well plates in a concen-
tration of 250 000 cells/well in 1ml of RPMI 10% FBS 1%
antibiotic/antimycotic solution. We exposed cells to
0.4 uCi/ml of [3H]thymidine for 16 h. Then cells were
washed 3 times with PBS 1 and fixed with 1ml of 5%
trichloroacetic acid in PBS for 15min at 4C. The fixative
solution was removed and cells were washed three times
with 1ml of methanol. After the total elimination of
methanol by air-drying cells were dissolved with 0.5ml
of NaOH 0.1M and 1% SDS and transferred to the
scintillation vial with 2.25ml of scintillation fluid and
mixed by vortex. The CPM was measured in the liquid
scintillation counter.
Quantification of cell activation by CD86 expression
EBV-infected or CD40L/IL-4-activated B cells were
harvested and stained for CD86 expression with an
anti-human CD86 FITC-conjugated (EuroBioSciences)
at 1:100 concentration. CD86 levels were determined by
flow cytometry (GalliosTM Flow Cytometer—Beckman
Coulter).
Antibodies
The following rabbit polyclonal antibodies were used:
H3K4me3 (Millipore CS200580), H3K9me3 (Millipore
07-442 (branched) / Abcam 8898), H3K27me3 (Millipore
07-449 for western blot; Diagenode cs-069-100 for ChIP
assays), H4K20me1 (Abcam ab9051), H4K20me2
(Millipore 07-1584) and H4K20me3 (Millipore 07-463).
We also used antibodies against the monoacetylated
forms at specific residues of histone H4 (K5, Millipore
07-327; K8, Abcam ab15823; K12, Abcam ab1761; and
K16, Millipore 07-329). Control antibodies for histone
H3 (Abcam ab1791-100) and H4 (Abcam ab10158) were
also used.
Western blotting
Histones were separated on 15% SDS-PAGE gel and
blotted onto a polyvinylidene difluoride membrane of
0.22mm pore size (Immobilon PSQ, Millipore). The
membrane was blocked in 5% milk PBS-T (phosphate-
buffered saline with 0.1% Tween-20) and immunoprobed
with antibodies raised against different peptides contain-
ing different histone modifications, as described above.
The secondary antibodies used were goat anti-rabbit
conjugated to horseradish peroxidase (HRP) (1:3000)
(Amersham) and sheep anti-mouse-HRP (1:5000).
Experiments were performed in triplicate. Bands were
quantitated by direct scanning of the western blot films
with a HP scanjet 4890 and processed with ImageJ
software.
Immunofluorescence
Cells were grown on coverslips in P60 dishes, fixed in
100% methanol, and stained as described previously
(14). Fluorochromes were DAPI and Alexa 488.
Confocal optical sections were obtained using a Leica
TCS SP5 Spectral confocal microscope (Leica
Microsystems) equipped with krypton and argon lasers.
Operation was done at a constant temperature of 22C.
Images were acquired with Leica Application Suite
Advanced Fluorescence (LAS AF) software and processed
with FIJI software using the following pluggins: Feature
Extraction-FeatureJ Laplacian (Copyright (C) Erik
Meijering) for H4K20me3 and Plot profile feature for
H3K27me3 and H3K4me3.
Mass spectrometry
Histone bands were excised from SDS-PAGE gels and di-
gested in-gel as described earlier in Jasencakova et al. (15).
Briefly, histones were destained and propionylated before
trypsin digestion was performed. After digestion, peptides
were desalted offline using Carbon carbon TopTips
(TT1CAR, Glygen) and reconstituted in 0.1% TFA.
The peptides were injected in an Ultimate 3000 HPLC
system (LC Packings Dionex and separated with a
gradient from 5% to 60% acetonitrile in 0.1% formic
acid over 40min at 300 nl/min on a C18 analytical
column (75 mm ID homepacked with ReproSil-Pur C18-
AQ 2.4mm from Dr Maisch). The effluent from the HPLC
was directly electrosprayed into the LTQ Orbitrap mass
spectrometer (Thermo Fisher Scientific). The MS instru-
ment was operated in the data-dependent mode to auto-
matically switch between full scan MS and MS/MS
acquisition. Survey full scan MS spectra (m/z 250 –
2000) were acquired in the Orbitrap with resolution
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R=60000 at m/z 400. The six most intense peptide ions
with charge states between two and five were sequentially
isolated (window=2.0m/z) to a target value of 10 000
and fragmented in the linear ion trap by collision-
induced dissociation (CID). Fragment ion spectra were
recorded in the Orbitrap part of the instrument. For all
measurements with the Orbitrap detector, three lock-mass
ions from ambient air (m/z=371.10123, 445.12002,
519.13882) were used for internal calibration. Typical
mass spectrometric conditions were: spray voltage
1.4 kV; no sheath and auxiliary gas flow; heated capillary
temperature 200C; normalized collision energy 35% for
CID in linear ion trap. An activation q=0.25 and activa-
tion time of 30ms were used. Peptides were quantified
using the peak area from the corresponding extracted
ion chromatograms (XICs, ±10 ppm).
Peptides were quantified using the peak area from the
corresponding XICs (±10ppm). To avoid differences
originating from the amount of material, digestion effi-
ciency and spray fluctuation during the LC-MS/MS
analysis, peptides were normalized to the peak area of
the corresponding heavy labeled peptides, spiked into
the sample prior to trypsin digestion.
ChIP assays
To isolate genomic sites associated with specific histone
modifications standard chromatin immunoprecipitation
(ChIP) assays were performed as previously described
(16). Commercial antibodies for H3K9Me3, H3K27me3,
H3K4me3 and H4K20me3, and H3 and H4 were
the same as those used for western blot analysis.
Immunoprecipitated material was used for analyses of
specific sequences by quantitative real time PCR (see
primers sequences in Supplementary Table S1) as well as
for hybridization on Southern blot assays.
Micrococcal nuclease and DNase I digestions and
Southern blot analysis
Resting and lymphoblastoid B cells were resuspended in
equal volumes of PBS and cell lysis buffer (0.65M
sucrose; 20mM Tris, pH 8; 10mM MgCl2; 2% Triton X-
100) and incubated on ice for 15min. Cells were centrifuged
at 1500 rpm for 5min, and the nuclear pellet was resus-
pended in 1ml of NT buffer (50mM Tris pH 7,4;
100mM NaCl; 5mM MgCl2; 5mM CaCl2; 1% NP-40;
1% Triton X-100). For both MNase and DNase I diges-
tions we followed the manufacturers’ instructions and
stopped the reactions at different times (30 s, 1, 2, 4, 8, 16
and 32min). MNase was used at 0.01 unit/ml and DNase I
at 1 unit/ml. Products of digestion products were separated
on 2% agarose gels. These gels were used in two alternative
experiments. In some cases, we performed quantitative
PCR to analyse fragments in the 5000 bp range isolated
from agarose gels (see primers sequences on Supplementary
Table S1). In other cases, we performed Southern blot,
to which end, DNA samples were transferred to Hybond-
N+ membranes and ChIP products were labeled with
[a32P]dCTP with the Ready-to-Go Labelling Kit
(Amersham) and used as a probe. Experiments were
performed with three biological replicates.
Bioinformatic analysis
Analysis of expression data
Normalized expression data were extracted from the GEO
database accession GSE30916 (17). Differential expression
(log2) was calculated from the average expression of LCLs
versus the average expression of primary B cells, corres-
ponding to matching paired samples from a total of five
individuals in duplicate. Probes were annotated to
EnsEMBL (version-65) genes (18) using Biomart (www.
biomart.org) database. In case of duplicate IDs we used
the highest absolute expression value for maximization.
ChIP-seq and DNase-seq data sources and data processing
Sources of ChIP-seq and DNAse-seq data are detailed
in Supplementary Table S2. We downloaded either
aligned BED format files or BAM format files from
public databases. BAM files were converted to BED
format files using BETools (bamToBed function) (19).
When there were more than one replicate, they were
concatenated to obtain wider coverage and greater
sequence depth.
Analysis of differential association of histone
modifications
Differential association (increased or decreased genomic
location) of H3K4me3, H3K27me3 and H3K9me3 was
analysed using the MACS program (version 2.0.9;
macs2diff function) (20) using the parameter settings: -g
hs –nomodel –shiftsize=75 –bdg -a 4 -q 0.005. Therefore,
q-value cutoff was established at 0.005. MACS’s macs2diff
function establishes differential regions by comparing two
treatment files corresponding to two conditions (in this
case, LCLs and RBLs), and comparing each of them
against corresponding control ‘Input’ files. This compari-
son generates an output containing a list of ‘differentially
bound locations’ with a ‘differential score’ (-Log10
q-value) where positive number means that the signal in
LCLs is higher than in RBLs, and negative number means
the opposite. Higher scores indicate that the difference
between the two cell types is larger. Both unique and con-
sistently found differentially bound locations were con-
sidered for further analysis, for example correlation with
expression. However, differential locations with score
(-Log10 q-value) exactly zero were removed from
analysis. When more than one replicate of the aligned
file were present, they were merged to ensure wider
coverage and greater sequencing depth. Significantly dif-
ferentially bound locations were annotated to the closest
EnsEMBL (version-65) transcripts and genes (18) using
BEDTools (closestBed function) (19). We calculated
Pearson’s correlation coefficient (PCC) between the differ-
entially bound location scores, in which negative and
positive values, respectively, indicate decreased and
increased location scores in LCLs/RBLs comparisons,
and the differentially expressed gene expression values
(log2-fold change; microarray data from GEO
GSE30916).
Analysis of differential accessibility at genome-wide level
DNase-seq (increase or decrease in open-chromatin
genomic location scores) in GM12878/CD20 was analysed
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using the SICER program (version 1.1; SICER-rb-df
function; window=200, gap=0, FDR=0.01) (21).
When more than one replicate of the aligned file was
present, they were merged to ensure more coverage and
sequencing depth. Identified significantly differentially
DNase-seq locations were annotated to the closest
EnsEMBL (version-65) transcripts and genes (18) using
BEDTools (closestBed function) (19).
We calculated PCC between the differential change in
open-chromatin location (negative and positive values,
respectively, indicate decreased and increased location
scores for the LCL/RBL comparison) and differentially
expressed gene expression values (log2-fold change; micro-
array data from GEO GSE30916; LCL/RBL).
Genomic location overlap analysis: Overlap of
decreased H3K9me3 and H3K27me3 locations with
increased Dnase-seq open-chromatin locations was
obtained using BEDTools (intersectBed function) (19).
In this case, the overlap has a threshold of at least 1 nt.
GO functional enrichment analysis
Functional annotation of differentially expressed genes is
based on Gene Ontology (GO) [(22); http://www.
geneontology.org], as extracted from EnsEMBL (version
65) (18). Accordingly, all genes are classified into three
ontology categories: (i) biological process (BP); (ii) cellular
component (CC); and (iii) molecular function (MF) and
pathways when possible. We took only the GO/pathway
categories, which have at least 10 genes annotated.
We used Gitools for enrichment analysis and heat-map
generation ((23); www.gitools.org). Resulting P-values
were adjusted for multiple hypothesis testing using
Benjamini and Hochberg’s False Discovery Rate (FDR)
method (24).
RESULTS
Loss and redistribution of H3K27me3, H3K9me3 and
H4K20me3 during EBV-mediated transformation of
B cells
EBV can very efficiently induce the activation and con-
tinuous proliferation of RBLs. This involves a dramatic
change in the biology of the cell, including an increase in
the nucleus size (Supplementary Figure S1) and expres-
sion changes affecting thousands of genes. To investigate
the potential involvement of changes in histone modifi-
cations in association with transformation of resting to
proliferating B cells, we first performed a time course
analysis of global levels of histone modifications by
western blot. We infected RBLs with EBV and analysed
the levels of H3K4me3, H3K9me3 and H3K27me3, as
well as the mono-, di- and trimethylated forms of K20
of histone H4 at different time points, up to 1 and 2
weeks after infection when cells have become LCLs
(Figure 1A). We also screened different histone H4
monoacetylated forms (H4K5Ac, H4K8Ac, H4K12Ac
and H4K16Ac) (Supplementary Figure S2). Our
analysis included control antibodies for the C-termini
of histones H3 and H4 and quantitation of three biolo-
gical replicates. To ensure the sensitivity of our system we
used a strain of EBV that infects B cells very efficiently
(12) (around 90% of B cells express the EBV transcrip-
tion factor EBNA-2 at 24 h) allowing inspection of
changes in histone modifications at early time points
after infection (24, 48 and 72 h), before cells display
active proliferation.
This analysis revealed a significant and progressive
decrease in histone modifications associated with repres-
sion, specifically H3K27me3, H3K9me3 and H4K20me3
(Figure 1A). In contrast, no differences were observed for
H3K4me3, an archetypical marker of gene activation,
and for the monoacetylated forms of histone H4
(Supplementary Figure S2). Scanning and quantitation
of the three independent experiments confirmed all these
observations (Figure 1B and Supplementary Figure S2).
A decrease in histone modifications associated with
repression and condensed chromatin is compatible with
the type of nuclear and expression changes associated
with B cell transformation.
We also compared the nuclear distribution of these
histone modifications in RBLs and LCLs. H4K20me3
staining in RBLs is characterized by a speckled pattern
with large foci. In LCLs, the size and number of foci
became smaller and the pattern observed was more
diffuse (Figure 1C and D). H3K27me3 showed a very dif-
ferent pattern, characterized in RBLs by a more diffuse
distribution with an accumulation of the signal toward the
periphery of nucleus. In LCLs, H3K27me3 showed a
sharper distribution with a less intense staining of the
central part of the nucleus and a stronger staining at the
periphery when compared to RBLs (Figure 1C and D). In
the case of H3K9me3, we did not observe a clear change
of distribution of the mark when comparing RBLs and
LCLs. We did not observe any changes for H3K4me3
either. In summary, our results not only revealed the
decrease in the global levels of heterochromatic histone
marks but also the acquisition of profound changes in
their nuclear distribution.
Changes in these histone modifications could be due
to several causes, including mistargeting and aberrant
overexpression or downregulation of the enzymes respon-
sible for the deposition of these marks. Interestingly, the
H3K27me3 demethylase KDM6B (JMJD3) has recently
been described as being induced by EBV (25). Also,
EZH2, the major H3K27 methyltransferase, is mutated
in certain B cell lymphomas (26). We therefore
checked the expression levels of these genes as well as
all those encoding for enzymes involved in the incorpor-
ation/elimination of H3K27me3, H3K9me3 and
H4K20me3 in an expression dataset corresponding
to both resting and proliferating B cells (GSE30916)
(17) (Supplementary Figure S3). Interestingly, some of
the genes encoding for these enzymes like EZH2,
SUV39H1 and SUV39H1 (H3K9 methyltransferase),
and SUV420H1 and SUV420H2 (H4K20 methyl-
transferase) displayed expression changes compatible
with the observed changes of their Lys substrates.
However, changes in other enzymes also targeting these
heterochromatin marks did not directly correlate with
the observed differences between RBLs and LCLs
(Supplementary Figure S3).
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Figure 1. Global analysis of histone modifications during EBV-mediated transformation from resting to proliferative B cells (A) Analysis by western
blot of a time course experiment with antibodies against H3K4me3, H3K9me3, H3K27me3 and total H3; H4K20me3, H4K20me2, H4K20me1 and
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Identification of genomic sites undergoing decreases
in H4K20me3, H3K27me3 and H3K9me3 during
EBV-mediated transformation of B cells
We then explored the genomic sites associated with the
losses of H3K27me3, H3K9me3 and H4K20me3 during
the EBV-mediated transformation of RBLs. H3K27me3
and H3K9me3 are present in facultative heterochromatin
which covers a wide range of genomic sites. To investigate
the genomic sites where H3K27me3 and H3K9me3
undergo changes between RBLs and LCLs, we
compared ChIP-seq data between resting and proliferating
B cells (GSE19465 for RBLs, ENCODE data for
GM12878 for LCLs, described in detail in Materials and
Methods section). We also analysed H3K4me3, for which
we had not observed overall changes in our initial
screening. This analysis revealed that a large number of
genomic sites have a reduced association with H3K27me3
and H3K9me3. For H3K27me3, 5724 unique genomic
sites featured a significant decrease in association from
RBLs to LCLs (q< 0.005) (Supplementary Table S3). In
the case of H3K9me3, 5298 unique sites underwent a
significant decrease from RBLs to LCLs (q< 0.005)
(Supplementary Table S3). Under the same conditions,
only 275 peaks were significantly reduced for H3K4me3.
This analysis not only showed that there was a much
higher proportion of sites displaying decreases than in-
creases in H3K27me3 and H3K9me3 for the transition
from RBLs to LCLs, but also that these changes affect
at many genomic sites. Gene ontology analysis of the gene
lists corresponding to the reductions in H3K27me3 and
H3K9me3 revealed significant enrichment of categories
related to cell division, positive regulation of cell prolifer-
ation and apoptosis for H3K27me3 and regulation of
transcription and apoptosis for H3K9me3 (Figure 2A).
We then looked at the identity of the genes undergoing
a decrease in H3K27me3 and H3K9me3. We found that
the two modifications were most substantially affecting at
the promoters of large classes of transcription factors. For
instance, the majority of theHOX cluster genes underwent
a decrease in H3K27me3 (Figure 2B, top) and most of the
zinc finger (ZNF) genes and coiled-coil domain-containing
(CCDC) genes showed a decrease in H3K9me3
(Figure 2B, bottom). This result is coincident with the
type of marks that characterizes each of the genes. HOX
genes are characterized by the presence of H3K27me3,
and this mark is maintained through the methyltransferase
EZH2 (27,28). ZNF genes are generally enriched in
H3K9me3 (28).
H3K27me3 and H3K9me3 are also present in constitu-
tive heterochromatin, associated with a variety of repeti-
tive elements including pericentromeric repeats, such as
Sat2 (29,30), and subtelomeric sequences like NLB2 and
D4Z4 (30). In the case of H4K20me3, this is the most
characteristic mark in this type of heterochromatin
(2,31). Using ChIP assays, we investigated the association
of the three marks with these repetitive elements.
Comparison of H4K20me3 in these repeats between
RBLs and LCLs revealed an enrichment of this mark
for RBLs in these repeats and a marked reduction in
LCLs (Figure 2C), whereas H4K20me3 was absent and
displayed no significant differences in euchromatic
control genes like GAPDH (Figure 2A). These results
reinforced the notion that changes in constitutive hetero-
chromatin occur during the EBV-mediated transform-
ation of cells. We observed a similar change for
H3K9me3 when comparing RBLs and LCLs
(Figure 2C). However, for H3K27me3 we observed
enrichment in this mark for Sat2 and NLB2 repeats,
consistent with the notion that this mark is also pre-
sent in constitutive heterochromatin (2), but this mark
did not decrease in the transformation to LCLs
(Figure 2C).
A reduction of the levels of H3K27me3 and H3K9me3
is likely to be linked to increased expression at the corres-
ponding genomic sites. We tested changes in expression
in association with genomic sites undergoing a significant
reduction in these heterochromatic marks. To this end,
we also used the expression data obtained from the
comparison of RBLs and B lymphoblasts (GSE30916)
(17). We found that most of the genes undergoing loss of
H3K27me3 also had increased expression (Supplementary
Table S4 and Figure 2D) (PCC=–0.027). This correl-
ation was not significant for genes undergoing a decrease
in H3K9me3 (PCC=0.067) (Supplementary Figure S4A).
The list of genes with an inverse correlation between
change in H3K27me3 and expression included several
involved in cell cycle regulation and differentiation, such
as CDKN3, CDKN2C, NFIB and SOCS2 (see original
ChIP-seq profiles and expression data in Supplementary
Figure S4B). Quantitative RT-PCR analysis confirmed the
increase in the expression levels of these genes between
RBLs and LCLs (Figure 2E). These results suggest that
the global decrease in H3K27me3 could have an effect in
the upregulation of genes that participate in the acquisi-
tion of the transformed phenotype.
Increased endonuclease accessibility during RBL to LCL
conversion
During transformation of resting to proliferating B cells
the size of cell nuclei increases suggesting the occurrence
of global decondensation. Also, an overall decrease in
these histone heterochromatin marks may be associated
with increased accessibility to endonucleases. To investi-
gate this possibility, we first compared the DNase-seq
Figure 1. Continued
total H4. (B) Densitometric quantitation of western blot data. The average of three independent experiments is represented. Data are normalized
against the amount of total histone. (C) Analysis of H3K4me3, H3K9me3, H3K27me3 and H4K20me3 distribution in resting and proliferative
B cells by immunofluorescence microscopy. Bars, 5 mm. (D) Quantitative analysis of immunofluorescence data. For H4K20me3, box and whisker
plots (top graphs) show the number of foci per cell, foci volume and intensity. The bottom and top of each box are the 25th and 75th percentile and
the bar near the middle the 50th percentile (the median). H3K27me3 and H3K4me3 cell diameter plots are represented at the bottom. Numbers are
the values of the integrated density of the total fluorescent emission per nuclear area of H3 and H4 signal. 50 nuclei were analysed in each case.
Values are shown as averages (±S.D.) in arbitrary units.
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Figure 2. Changes in heterochromatic histone modifications in specific sequences. (A) Gene ontology biological process analysis of the sites with
differential association for H3K27me3 and H3K9me3. The bar length is proportional to the number of genes for a given category. (B) Examples of
gene clusters that exhibit significant decreases during the conversion of RBLs to LCLs. The HOXA cluster (at chromosome 7) for H3K27me3 and
ZNF cluster (at chromosome 19) for H3K9me3. The y-axis shows the differential association of these two histone marks between RBLs and LCLs.
(C) Quantitative ChIP assays showing changes in H4K20me3, H3K27me3 and H3K9me3 between RBLs and LCLs at repetitive sequences (SAT2,
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profiles of RBLs and LCLs (data from the ENCODE
database; analysis described in detail in Materials and
Methods section). Comparison of the data corresponding
to RBLs and LCLs revealed that 71 349 genomic sites
had greater accessibility, whereas only 12 656 showed
decreased accessibility (Supplementary Figure S4C).
This predominance of higher accessibility is also compat-
ible with the increase in nucleus size and a global gene
upregulation. We also tested changes in expression
associated with genomic sites that undergo increased acces-
sibility. This analysis led to the identification of 7361 genes
undergoing an increase of expression (Supplementary
Table S5 and Supplementary Figure S4D). Among the
genes that show increased accessibility and higher expres-
sion levels we identified a number of genes that are
relevant to the cell-growth checkpoints and signal trans-
duction mechanisms. This includes genes like regulator of
G-protein signaling RGS1, several cytokines (IL1A, IL-
4I1, IL32, CCL3, CCR8, CCL17, CCL22, CCL23,
CCL25, etc.), various interferon-related genes (IFNA2,
IFI44L, IFITM1, IFIT3, IFIH1, IRF4, IFI27L1, etc.) as
well as well-known EBV-induced genes like EBI3.
As indicated above, it is generally assumed that het-
erochromatic histone marks are associated with a more
condensed conformation refractory to endonuclease
digestion. To explore the potential relationship
between decrease in histone heterochromatic marks
and increased endonuclease accessibility, we first
combined the DNase accessibility data with genomic
sites for differential binding of H3K27me3 and
H3K9me3 and found that the overlap was not significant
since only a small proportion of sites were actually
undergoing both events simultaneously (Supplementary
Figure S4E).
We then investigated the accessibility at specific
sequences that undergo a decrease in H4K20me3 (D4Z4,
Sat2 and NBL2 repeats), H3K27me3 (HOXA1, GMR8)
and H3K9me3 (ZNF717, MAPK6) using DNaseI diges-
tion followed by amplification by quantitative PCR with
primers for these sequences. We cut the DNase-resistant
fraction (size range 5000 bp, see top panel of Figure 3A)
at different time points and amplified all the above repeti-
tive elements and other sequences. This strategy allowed
us monitoring the dynamics of digestion providing an es-
timation of accessibility to DNase. In these experiments
we used ACTIN and IL17A as negative and positive
controls, respectively, of genes with equal or differential
accessibility between RBL and LCL, from the analysis of
the DNase-seq data described above. ACTIN was found
to be rapidly digested in both RBL and LCL, whereas
IL17A is slowly digested in RBLs but rapidly digested in
LCLs. Analysis of these sequences also confirmed the
validity of our analysis. In the case of subtelomeric
repeats (D4Z4) non-satellite repeats we observed for
RBLs an increase in these sequences at early digestions
points with respect to initial time (Figure 3A). This is con-
sistent with the higher resistance to digestion of these
regions, which are highly compact, that causes a propor-
tional enrichment. In LCLs, we observed a lower enrich-
ment and a higher digestion rate for D4Z4 repeats,
compatible with the reduction in this type of constitutive
heterochromatin in proliferating cells. However, in other
cases (NBL2, HOXA1, GMR8, ZNF717) we did not
observe significant differences in the dynamics of digestion
between RBLs and LCLs (Figure 3A), indicating that
these sequences that display differential enrichment for
H4K20me3, H3K27me3 and H3K9me3 were similar in
their accessibility to DNase I between these two situations.
Interestingly, in other sequences displaying a slow DNase
I digestion dynamics in RBLs (MAPK6, with a loss of
H3K9me3 in LCLs) we also observed increased accessibil-
ity in LCLs (Figure 3A, bottom).
Finally, we investigated whether increased accessibility
was physically associated with specific changes in the
histone methylation profile by combining digestion with
MNase coupled to hybridization with DNA probes
prepared from ChIP experiments with the three different
histone modifications (H3K27me3, H3K9me3 and
H4K20me3) (Figure 3B, top panel). This type of experi-
ment enabled us to test the accessibility to MNase in
sequences bound to these different heterochromatin
marks in RBLs and LCLs. We first compared the
MNase sensitivity of RBLs and LCLs (Figure 3B, top
left). We observed an identical digestion dynamics of
bulk chromatin. We then used H3K27me3-, H3K9me3-,
H4K20me3- enriched materials from RBLs and
hybridized it against both RBL and LCL MNase-
digested chromatin fragments. Comparison between
RBLs and LCLs did not show any significant difference
in the dynamics of accessibility to MNase digestion of the
chromatin for any of the three heterochromatic histone
marks (Figure 4C and D). However, we cannot discard
that changes are occurring in the proximity of the
genomic sites adjacent to these heterochromatic histone
marks, however for the following experiments we
focused on histone modification changes.
Loss of H3K27me3, H3K9me3 and H4K20me3 is directly
associated with EBV-mediated transformation of B cells
and not with the acquisition of proliferation
Infection of RBLs with EBV results in activation to
lymphoblasts that are phenotypically similar to those
generated by physiological stimulation with CD40L plus
IL-4. One important difference is that EBV infection leads
to the establishment of permanently growing LCLs,
whereas CD40L/IL-4 blasts have finite proliferation life-
spans. Our results indicated that decrease in H3K27me3,
H3K9me3 and H4K20me3 is already substantial at early
Figure 2. Continued
D4Z4, NBL2) characterized by constitutive heterochromatin. GAPDH is used as a control gene. (D) Analysis of expression changes for genomic sites
undergoing a decrease in H3K27me3. All genes displaying a decrease in H3K27me3 enrichment in LCLs with respect to RBLs (blue bars) are shown
including their corresponding change in expression (red bars), both in log2 scale. (E) Quantitative RT-PCR analysis showing a couple of example of
genes displaying decreased H3K27me3 in LCls with respect to RBLs and increased expression in LCLs. Data are normalized against the RPL38 gene.
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Figure 3. Independence of loss of heterochromatic marks and increased in accessibility during transformation of RBLs to LCLs. (A) Top panel,
scheme depicting the flowchart of the DNaseI-qPCR analysis. Bottom panel, high molecular weight fragments in a time course DNaseI digestion of
RBLs and LCLs. ACTIN and IL17A are used as negative and positive controls, respectively, of genes with equal or differential accessibility between
RBL and LCL. Specific sequences that undergo a decrease in H4K20me3 and H3K9me3 (D4Z4 and NBL2 repeats), H3K27me3 (HOXA1, GMR8)
and H3K9me3 (ZNF717, MAPK6) were analysed. (B) Top panel, scheme depicting the flowchart of the Southern blot-ChIP based analysis of
MNase-digested samples. DNA from CHIP experiments with H3K9me3, H3K27me3 and H4K20me3 material are shown. (C) Quantitation of
Southern blot analysis. Scans of the large DNA fragments and mononucleosomal-size fragments over time are shown.
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Figure 4. Comparison of histone modification changes during transformation of RBLs with mutant forms of EBV and IL-4/CD40L-stimulated cells.
(A) Comparison of activation and proliferation levels between B cells infected with wild type EBV (WT EBV), the LMP-1 and EBNA-2 deficient
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time points, when the proliferation rates and activation
levels of B cells are not so different between cells
infected with EBV or stimulated with CD40L/IL-4. To
investigate whether the described global chromatin
changes are directly associated with EBV-mediated trans-
formation and are not just a mere effect of B cell activa-
tion or the acquisition of a proliferative phenotype, we
focused on the acquisition of changes in H3K27me3,
H3K9me3 and H4K20me3 in B cells activated/stimulated
with IL-4 and CD40L. Under our conditions we observed
similar levels of cell activation in B cells activated with
CD40L/IL-4 when compared to EBV-infected B cells,
measured by cytometry analysis of the CD86 surface
marker (Figure 4A), and higher proliferation rates for
CD40L/IL-4-activated cells, measured by tritiated thymi-
dine incorporation (Figure 4A). However, when looking
at the levels of H3K9me3 and H4K20me3 over time we
did not observe any decrease in B cells stimulated with
CD40L/IL-4, in contrast with our observations for EBV-
stimulated cells (Figure 4C, bottom). We only observed
moderate changes for H3K27me3 (Figure 4C and D),
but much lower than those observed for B cells infected
with EBV. These results suggest that differences between
these two related mechanisms are relevant in the acquisi-
tion of changes in these histone modifications.
In parallel, we stimulated B cells with two different re-
combinant forms of EBV where the EBNA-2 (32) and
LMP-1 (9) genes, the two major EBV-encoded proteins,
are deleted. Under these conditions, cells undergo a few
divisions but do not acquire the capability of unlimited
growth. Analysis of the activation levels for these EBV
forms were similar to the levels observed for wild type
EBV or cells activated with CD40L/IL-4 (Figure 4A),
however B cells infected with EBNA-2-deficient EBV
had a much lower proliferation rate than wild type EBV
(Figure 4A). Interestingly, we found that B cells infected
with any of these two EBV recombinant forms underwent
a decrease in H3K27me3, H3K9me3 and H4K20me3
similar to that seen in wild type EBV, regardless of their
proliferation rates (Figure 4C and D). These results were
independently confirmed by mass spectrometry analysis,
which also showed that both forms of EBV (deficient
for EBNA-2 or LMP-1) resulted in reduced H3K27me3
levels, albeit to a lesser degree than wild type EBV.
In contrast, we did not observe a change in H3K27me3
when B cells were activated with CD40L/IL-4 (Figure 4E).
All together, this set of data indicates that the changes
observed for these marks in association with EBV infec-
tion are not related with the acquisition of the ability to
proliferate but it is a direct effect of the transformation
mediated through EBV. We also tested the ability of
LMP-1 alone to influence on the levels of these histone
marks. We chose LMP-1 because its autonomous poten-
tial of growth-transforming cells (33). To this end we
infected cells previously activated with CD40L/IL-4 with
a lentiviral construct expressing LMP-1. We obtained ef-
ficient levels of infection with LMP-1 during the course of
the first week as quantitated by measuring the incorpor-
ation of GFP by flow cytometry (Figure 4B). In this case,
we obtained similar results to those in cells activated by
CD40L/IL-4 alone, i.e. absence of global changes in het-
erochromatic marks (Figure 4C and D) with the exception
of a moderate reduction in H3K27me3. Overall, these
results are in line with the observations by others, where
full transformation of B cells by EBV cannot be attributed
to a single viral oncogene and rather, the cooperative
functions of multiple viral genes are required.
We also compared the acquisition of changes in these
marks between wild type and defective EBV forms and
CD40L/IL-4-stimulated cells at the gene-specific level by
performing ChIP assays. We tested changes in
H4K20me3, H3K27me3 and H3K9me3 at candidate se-
quences and genes selected from our comparison of ChIP-
seq data. This analysis not only allowed us to perform
gene-specific comparisons between the different situations
explored above, but also validated the results from the
comparison of ChIP-seq data. We observed that both
the wild type and two mutant forms of EBV were able
to reduce the levels of H4K20me3 at Sat2 and D4Z4
repeats. We also observed that B cells infected with the
LMP1-expressing lentivirus had the levels of H4K20me3
reduced in D4Z4 repeats (Figure 4F). For H3K27me3 and
H3K9me3 we observed results in line with the ones
obtained in the global analysis, however specific sequences
revealed different contributions for each of the conditions
(Figure 4F).
DISCUSSION
Our results provide evidence that EBV-mediated
transformation of B cells associates with both global
decrease in heterochromatin histone post-translational
Figure 4. Continued
forms of EBV (LMP1 KO and EBNA2 KO), and cells stimulated with IL-4/CD40L (ACT). The left panel shows the proportion of activated cells
(left; determined by FACS analysis with CD86) and the right panel the proportion of dividing cells (determined with tritiated thymidine).
(B) Quantitation of levels of infection with LMP1-expressing lentivirus measured by GFP fluorescence and FACS analysis. (C) Analysis by
western blot of a time course experiment with antibodies against H3K4me3, H3K9me3, H3K27me3, total H3, H4K20me3 and total H4 of RBLs
infected with wild type EBV, EBV deficient for LMP-1, EBV deficient for EBNA-2, IL-4/CD40L-stimulated B cells and IL-4/CD40L-stimulated B
cells infected with LMP-1. (D) Densitometric quantitation of western blot data. The average of three independent experiments is represented. Data
are presented relative to levels in RBL. (E) Top panel, XIC of isobaric H3 peptides from different B-cell populations. Differentially modified peptides
were chromatographically separated and individual peaks identified by tandem MS spectra. Relative levels of individual isoforms were quantified
using the Genesis peak detection module of the Xcalibur software package (Thermo Fisher Scientific). X-axis represents retention time, y-axis the
intensity of ion currents in the Orbitrap mass spectrometer. Bottom panel, bar chart of H3K27me3 levels relative to the two other modification states
of this peptide. Error bars represent the SD of two independent biological replicates. Abbreviations: unmod=unmodified peptide, me1= single
mono-methylated lysine. (F) Quantitative ChIP assays showing changes in H4K20me3, H3K27me3 and H3K9me3 between RBLs and B cells infected
wild type EBV, EBV deficient for LMP-1, EBV deficient for EBNA-2, IL-4/CD40L-stimulated B cells and IL-4/CD40L-stimulated B cells infected
with LMP-1 (LMP1 LV). The sequences correspond to promoter gene sequences from the ChIP-seq analysis. GAPDH was used as a control
sequence.
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modifications (H3K9me3, H3K27me3 and H4K20me3)
and increased chromatin accessibility to endonucleases.
These two types of changes affect thousands of genomic
sites. Comparison of these results with those obtained by
activating and inducing proliferation with T cell-derived
mitogens CD40L and IL-4, as well as with EBV mutants,
indicates that the process is specific to the changes
occurring associated with grow transformation and not
by just pure induction of cell proliferation. We have also
observed that the two types of chromatin changes, hetero-
chromatin mark levels and chromatin accessibility, do
not necessarily overlap, despite the general notion that
heterochromatic marks are associated with chromatin
compaction.
Our first finding indicates that loss of heterochromatic
histone marks is predominant over changes in euchro-
matic marks. The observed losses for H3K9me3,
H3K27me3 and H4K20me3 are not apparent for
activating histone modifications like H3K4me3 or the
acetylated forms of histones H3 and H4. Decreases in
these heterochromatic marks are not only evident when
looking at their global levels, but also when analysing
genomic sites to which these marks are associated, as
evidenced from both candidate sequence analysis and
genome-wide analysis. Changes affect pericentromeric
and subtelomeric repeats, especially for H4K20me3 and
H3K9me3, and thousands of genomic sites in facultative
heterochromatin for H3K27me3 and H3K9me3.
Our analysis also revealed an increase in accessibility to
endonucleases when comparing RBLs and LCLs. This
finding is compatible with the general observation that
conversion of RBLs to LCLs results in a significant
enlargement of the nucleus. At the molecular level, acces-
sibility to endonucleases is an experimental measurement
of loosening of chromatin. Also, changes in accessibility at
genomic sites associated with overexpression of several
thousand genes. All together, our study is the first descrip-
tion of a predominant change in heterochromatic marks
and chromatin accessibility associated with a functional
change in expression during cell transformation.
An unexpected observation was the inability to demon-
strate in some cases an overlap between the sequences that
undergo a decrease in heterochromatic marks and
increased accessibility, despite the general notion that
these elements (heterochromatic histone marks and chro-
matin compaction) are linked. There are several potential
explanations for this observation. A sudden change in the
cell cycle/division status of the cell, including transform-
ation from a quiescent to proliferative status in aberrant
context, may result in inefficient maintenance of the
epigenetic marks. We have also observed a similar
behavior when focusing on DNA methylation during the
conversion of resting to proliferating B cells (34), that is
decreased in genes in euchromatic regions, particularly
those regulated by B cell specific factors. In this context
of inefficient maintenance, different elements of the
epigenetic and nuclear organization machinery that are
normally coupled may find their links loosened. A study
has recently shown independence between chromatin
compaction and histone modifications, in cells deficient
for DNA methyltransferases (35). However, we cannot
discard that there is increased accessibility in regions
close (upstream or downstream) to those undergoing
these changes in histone modifications and therefore
further analysis will be required. In the context of this
study, we therefore focused our attention in heterochro-
matic histone modifications as their changes were more
robustly associated with the growth transformation
process.
One of the questions arising from these results is whether
changes at these marks occur concomitantly with cells
acquiring the ability to proliferate, or if an initial change
is directly responsible for the deposition or removal of
these marks. Recent evidence has shown that increased
and decreased activity of enzymes controlling H3K27me3
contributes to carcinogenesis. This includes both EZH2
(26), KDM6B/JMJD3 (25) and UTX. For instance,
JMJD3 (the main H3K27me3 demethylase) has been
reported to be induced by EBV (25). In addition, other
Polycomb group factors are regulated by EBV proteins.
For instance, Bmi1 is upregulated by LMP-1 (36). Our
analysis on the global levels of enzymes responsible
for the maintenance of H3K27me3, H3K9me3 and
H4K20me3 revealed certain trends in expression changes
of histone methyltransferases (EZH2, for H3K27;
SUV39H1 and SUV39H2 for H3K9; and SUV420H1 and
SUV420H2 for H4K20) compatible with the observed
changes in those histone heterochromatic marks.
However, other enzymes did no correlate and further func-
tional dissection will be required to determine whether
global changes in these enzymes are related to changes
in these histone marks during transformation of B cells.
To address the possibility that the observed changes
associated with EBV-mediated transformation of B cells
are mainly driven by the acquired ability of cells to pro-
liferate, we compared the results with those obtained
by stimulating B cells with IL-4/CD40L. Both EBV-
mediated transformation and CD40L/IL-4-activation
share cellular pathways (3). In this case, we observed
that IL-4/CD40L-mediated activation of B cells that
results in active proliferation does not lead to a loss in
heterochromatic marks.
Following EBV infection of RBLs in vitro, EBNA-2
drives B cell transformation into LCLs by acting as a
potent transcriptional activator of both viral and cell
genes which in turn will then cause survival and prolifer-
ation of the infected cells. Among the viral EBNA-2-
targets, LMP-1 is the major EBV oncogene and is
required for initiation of primary B cell transformation
in vitro (8) and also for maintenance of continuous prolif-
eration of EBV-LCLs (9). Interestingly, LMP-1 and
EBNA-2 deficient EBV, which are less efficient in
stimulating proliferation (particularly EBNA-2 deficient
EBV viral particles) still induced the loss heterochromatin
marks. This dissection allowed us to separate the effects of
proliferation from the direct influence of the EBV infec-
tion in transforming B cells. On the other hand, the sole
infection with LMP-1 did have only moderate effects in
some of these marks, indicating its participation in the
acquisition of histone heterochromatin changes but also
the need of the cooperative function of additional viral
genes, in agreement with the results by others. Recent
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data have shown a prominent role of other EBV proteins
in inducing chromatin changes during transformation.
For instance, EBNA-1 mediates recruitment of a histone
H2B deubiquitylating complex to the EBV latent origin of
DNA replication (37). EBNA-1 has also been shown to
interact with multiple nuclear proteins (38) and can
promote large-scale chromatin decondensation mediated
by a bipartite Gly-Arg domain of this protein that resem-
bles the AT-hook of HMGA (39). Similar effects in chro-
matin accessibility or induction of histone modification
changes have been observed in the homologs encoded by
other gamma herpesviruses, for example LANA-1 in
Human Herpes Virus 8 (40) or others (41). In this sense,
it will be important to test the role of EBNA-1 and other
EBV proteins in the acquisition of the chromatin changes
described in this study.
As explained above, quiescent differentiated cells have a
restricted transcription program, in which only a limited
set of genes (ubiquitously expressed and cell type specific
genes) are expressed. This progressive restriction of the
transcription program, as well as the increase in both
facultative and constitutive heterochromatin marks
(2,42), is well-known to occur during differentiation.
EBV-mediated transformation could therefore be viewed
as an inverse process to that occurring during differenti-
ation, and some of the mechanisms involved are likely to
act in an opposite direction to those driving differenti-
ation. In this sense, our data fit very well with this
notion, since we found that the decrease in some of
these heterochromatin marks, specifically H3K27me3, is
associated with an increase in expression. However, to
the best of our knowledge, this is the first report of such
a connection being established. Our observation of
decreased levels of H4K20me3 are also compatible with
the general finding that loss of this mark is a common
hallmark of human cancer (30). Other studies have also
shown decreased H3K9me3 and H3K27me3 levels in dif-
ferent cancer types (43–45). In this sense, our findings
suggest that B cell transformation-associated loss of
H4K20me3 and other heterochromatin histone marks
might represent an early step in lymphomagenesis, or
more in general, perhaps in carcinogenesis.
Our study has led to identification of a novel phenom-
enon implicating global chromatin changes related to
EBV-mediated transformation of B cells. Our analysis of
a related mechanism stimulating B cell proliferation,
together with the analysis of the effects of recombinant
EBV forms, highlights the association of these changes
with growth transformation but not with the pure acqui-
sition of proliferation capabilities.
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Supplementary Data are available at NAR Online.
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